Copyright Reports & Markets. All rights reserved.

Global Inhalation Anesthesia Market Research Report 2021

Buy now

1 Inhalation Anesthesia Market Overview

  • 1.1 Product Overview and Scope of Inhalation Anesthesia
  • 1.2 Inhalation Anesthesia Segment by Type
    • 1.2.1 Global Inhalation Anesthesia Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Sevoflurane
    • 1.2.3 Desflurane
    • 1.2.4 Isoflurane
  • 1.3 Inhalation Anesthesia Segment by Application
    • 1.3.1 Inhalation Anesthesia Sales Comparison by Application: (2021-2027)
    • 1.3.2 Induction
    • 1.3.3 Maintenance
  • 1.4 Global Inhalation Anesthesia Market Size Estimates and Forecasts
    • 1.4.1 Global Inhalation Anesthesia Revenue 2016-2027
    • 1.4.2 Global Inhalation Anesthesia Sales 2016-2027
    • 1.4.3 Inhalation Anesthesia Market Size by Region: 2016 Versus 2021 Versus 2027

2 Inhalation Anesthesia Market Competition by Manufacturers

  • 2.1 Global Inhalation Anesthesia Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Inhalation Anesthesia Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Inhalation Anesthesia Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Inhalation Anesthesia Manufacturing Sites, Area Served, Product Type
  • 2.5 Inhalation Anesthesia Market Competitive Situation and Trends
    • 2.5.1 Inhalation Anesthesia Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Inhalation Anesthesia Players Market Share by Revenue
    • 2.5.3 Global Inhalation Anesthesia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Inhalation Anesthesia Retrospective Market Scenario by Region

  • 3.1 Global Inhalation Anesthesia Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Inhalation Anesthesia Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Inhalation Anesthesia Market Facts & Figures by Country
    • 3.3.1 North America Inhalation Anesthesia Sales by Country
    • 3.3.2 North America Inhalation Anesthesia Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Inhalation Anesthesia Market Facts & Figures by Country
    • 3.4.1 Europe Inhalation Anesthesia Sales by Country
    • 3.4.2 Europe Inhalation Anesthesia Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Inhalation Anesthesia Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Inhalation Anesthesia Sales by Region
    • 3.5.2 Asia Pacific Inhalation Anesthesia Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Inhalation Anesthesia Market Facts & Figures by Country
    • 3.6.1 Latin America Inhalation Anesthesia Sales by Country
    • 3.6.2 Latin America Inhalation Anesthesia Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Inhalation Anesthesia Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Inhalation Anesthesia Sales by Country
    • 3.7.2 Middle East and Africa Inhalation Anesthesia Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global Inhalation Anesthesia Historic Market Analysis by Type

  • 4.1 Global Inhalation Anesthesia Sales Market Share by Type (2016-2021)
  • 4.2 Global Inhalation Anesthesia Revenue Market Share by Type (2016-2021)
  • 4.3 Global Inhalation Anesthesia Price by Type (2016-2021)

5 Global Inhalation Anesthesia Historic Market Analysis by Application

  • 5.1 Global Inhalation Anesthesia Sales Market Share by Application (2016-2021)
  • 5.2 Global Inhalation Anesthesia Revenue Market Share by Application (2016-2021)
  • 5.3 Global Inhalation Anesthesia Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 AbbVie Inc.
    • 6.1.1 AbbVie Inc. Corporation Information
    • 6.1.2 AbbVie Inc. Description and Business Overview
    • 6.1.3 AbbVie Inc. Inhalation Anesthesia Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 AbbVie Inc. Product Portfolio
    • 6.1.5 AbbVie Inc. Recent Developments/Updates
  • 6.2 Baxter
    • 6.2.1 Baxter Corporation Information
    • 6.2.2 Baxter Description and Business Overview
    • 6.2.3 Baxter Inhalation Anesthesia Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Baxter Product Portfolio
    • 6.2.5 Baxter Recent Developments/Updates
  • 6.3 Piramal Enterprises Limited
    • 6.3.1 Piramal Enterprises Limited Corporation Information
    • 6.3.2 Piramal Enterprises Limited Description and Business Overview
    • 6.3.3 Piramal Enterprises Limited Inhalation Anesthesia Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Piramal Enterprises Limited Product Portfolio
    • 6.3.5 Piramal Enterprises Limited Recent Developments/Updates
  • 6.4 Halocarbon Products Corporation
    • 6.4.1 Halocarbon Products Corporation Corporation Information
    • 6.4.2 Halocarbon Products Corporation Description and Business Overview
    • 6.4.3 Halocarbon Products Corporation Inhalation Anesthesia Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Halocarbon Products Corporation Product Portfolio
    • 6.4.5 Halocarbon Products Corporation Recent Developments/Updates
  • 6.5 Hikma Pharmaceuticals PLC
    • 6.5.1 Hikma Pharmaceuticals PLC Corporation Information
    • 6.5.2 Hikma Pharmaceuticals PLC Description and Business Overview
    • 6.5.3 Hikma Pharmaceuticals PLC Inhalation Anesthesia Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Hikma Pharmaceuticals PLC Product Portfolio
    • 6.5.5 Hikma Pharmaceuticals PLC Recent Developments/Updates
  • 6.6 Lunan Pharmaceutical Group Co.Ltd.
    • 6.6.1 Lunan Pharmaceutical Group Co.Ltd. Corporation Information
    • 6.6.2 Lunan Pharmaceutical Group Co.Ltd. Description and Business Overview
    • 6.6.3 Lunan Pharmaceutical Group Co.Ltd. Inhalation Anesthesia Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Lunan Pharmaceutical Group Co.Ltd. Product Portfolio
    • 6.6.5 Lunan Pharmaceutical Group Co.Ltd. Recent Developments/Updates
  • 6.7 Jiangsu Hengrui Medicine Co. Ltd.
    • 6.6.1 Jiangsu Hengrui Medicine Co. Ltd. Corporation Information
    • 6.6.2 Jiangsu Hengrui Medicine Co. Ltd. Description and Business Overview
    • 6.6.3 Jiangsu Hengrui Medicine Co. Ltd. Inhalation Anesthesia Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Jiangsu Hengrui Medicine Co. Ltd. Product Portfolio
    • 6.7.5 Jiangsu Hengrui Medicine Co. Ltd. Recent Developments/Updates
  • 6.8 Fresenius Kabi Ag
    • 6.8.1 Fresenius Kabi Ag Corporation Information
    • 6.8.2 Fresenius Kabi Ag Description and Business Overview
    • 6.8.3 Fresenius Kabi Ag Inhalation Anesthesia Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Fresenius Kabi Ag Product Portfolio
    • 6.8.5 Fresenius Kabi Ag Recent Developments/Updates

7 Inhalation Anesthesia Manufacturing Cost Analysis

  • 7.1 Inhalation Anesthesia Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Inhalation Anesthesia
  • 7.4 Inhalation Anesthesia Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Inhalation Anesthesia Distributors List
  • 8.3 Inhalation Anesthesia Customers

9 Inhalation Anesthesia Market Dynamics

  • 9.1 Inhalation Anesthesia Industry Trends
  • 9.2 Inhalation Anesthesia Growth Drivers
  • 9.3 Inhalation Anesthesia Market Challenges
  • 9.4 Inhalation Anesthesia Market Restraints

10 Global Market Forecast

  • 10.1 Inhalation Anesthesia Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Inhalation Anesthesia by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Inhalation Anesthesia by Type (2022-2027)
  • 10.2 Inhalation Anesthesia Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Inhalation Anesthesia by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Inhalation Anesthesia by Application (2022-2027)
  • 10.3 Inhalation Anesthesia Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Inhalation Anesthesia by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Inhalation Anesthesia by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Sevoflurane
    Desflurane
    Isoflurane

    Segment by Application
    Induction
    Maintenance

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    By Company
    AbbVie Inc.
    Baxter
    Piramal Enterprises Limited
    Halocarbon Products Corporation
    Hikma Pharmaceuticals PLC
    Lunan Pharmaceutical Group Co.Ltd.
    Jiangsu Hengrui Medicine Co. Ltd.
    Fresenius Kabi Ag

    Buy now